Subscribe

Under What Conditions Can The Extraction Liquid Of Dressings Be Accepted After PH Adjustment, Centrifugation, And Other Treatments? Should Samples Be Characterized Before And After Treatment, And What Key Indicators Should Be Focused On?

2024-07-04

If the pH of the dressing itself is abnormal or the extraction liquid cannot be tested, results without treatment should also be provided.

Suggested Reading

GB/T 16886.1-2022 includes implantation in the biological evaluation of dressings. How should implantation tests…
Why is the extraction period typically 24 hours in China for cytotoxicity testing?
GB/T 16886.11-2021 adds tests for subchronic systemic toxicity evaluation with dual-route exposure. Which…
How is the endotoxin limit for wound dressing products determined?
What factors may affect biocompatibility risk when using biological test data from similar devices for…
What are the key focus areas in the evaluation of acute, subacute, subchronic, and chronic toxicity, and can…
Can products made from materials conforming to YY 0341.1 Appendix B be exempted from biological evaluation?
Do all medical devices require chemical characterization?
When combining subchronic and implantation tests in one project, what factors need to be considered, and how can…
How should the evaluation of new items in the endpoint table be considered after the implementation of the new…
For subchronic systemic toxicity studied via implantation, what is the basis for determining the implantation…

Previous: How should the evaluation of new items in the endpoint table be considered after the implementation of the new GB/T 16886.1, and what is the background of the ISO revision?